Psychiatry & Neurology Doctors in New Castle, PA Accepting Medicare

4 Psychiatry & Neurology doctors found. Showing 1 - 4

Dr. Mark Ayad Matta, DO Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 2616 Wilmington Rd, Suite A, New Castle, PA 16105 Phone: 724-652-2323    Fax: 724-654-3461

Dr. William Randolph Richardson, M.D. Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 11 Shenango Rd, Ste 1, New Castle, PA 16105 Phone: 724-657-1881    Fax: 724-657-9178

Dr. Anna B. Kosturek, M.D. Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 130 W North St, New Castle, PA 16101 Phone: 724-658-3578    Fax: 724-656-1325

Dr. Rasim Somer Diler, MD Psychiatry & Neurology - Forensic Psychiatry Medicare: Medicare Enrolled Practice Location: 2703 W State St, New Castle, PA 16101 Phone: 724-657-3303    Fax: 724-657-3326

News Archive

Resolution to train public, professional responders in bleeding control techniques receives overwhelming support

Yesterday the American Medical Association's House of Delegates approved a resolution introduced by the American College of Surgeons and other medical societies to train more professional first responders (i.e., police and firefighters) and civilians as immediate responders in the essential techniques of bleeding control and to place bleeding control kits (containing tourniquets, pressure bandages, hemostatic dressings, and gloves) with first responders.

Researchers report a case of S-ICD implantation in patient with ccTGA and DDD pacemaker

In a new publication from Cardiovascular Innovations and Applications; Yu Zhang, Wen-Long Dai, Can-Can Lin, Qiao-Yuan Li and Cheng-Jun Guo from Beijing Anzhen Hospital, Capital Medical University, Beijing, China consider implantation of an S-ICD in a patient with a DDD pacemaker and congenitally corrected transposition of the great arteries.

Forest Laboratories, Almirall report positive topline results from AUGMENT COPD

Forest Laboratories, Inc. and Almirall, S.A. today announced positive topline results from AUGMENT COPD, the second six-month pivotal phase III clinical trial evaluating the efficacy and safety of investigational fixed dose combinations of aclidinium bromide and formoterol fumarate, delivered in the Pressair (Genuair outside the USA) inhaler.

Use of hookah steam stones could lead to dangerous, false sense of security

New research suggests the use of hookah steam stones - commonly considered a safer alternative to cigarette smoking - could be leaving users with a dangerous, false sense of security. The findings out of the University of Cincinnati/Agilent Technologies Metallomics Center of the Americas are published this month in the Microchemical Journal.

Read more Medical News

› Verified 1 days ago